These authors contributed equally to this work.
Critical role of CD40-mediated autocrine tumor necrosis factor-alpha in potentiation of cisplatin-induced cytotoxicity in cancer cells
Version of Record online: 17 NOV 2011
© 2011 Japanese Cancer Association
Volume 103, Issue 2, pages 197–202, February 2012
How to Cite
Sun, H., Zhong, Y.-J., Zheng, X.-L., Wang, Q., Yang, L., Shi, F., Yan, J.-Q., He, F., Liao, L.-C., Lin, Y., Zhang, L. and Wang, X. (2012), Critical role of CD40-mediated autocrine tumor necrosis factor-alpha in potentiation of cisplatin-induced cytotoxicity in cancer cells. Cancer Science, 103: 197–202. doi: 10.1111/j.1349-7006.2011.02122.x
- Issue online: 1 FEB 2012
- Version of Record online: 17 NOV 2011
- Accepted manuscript online: 19 OCT 2011 11:24AM EST
- (Received June 27, 2011/Revised October 12, 2011/Accepted October 13, 2011/Accepted manuscript online October 19, 2011)
Fig. S1. rsCD40L enhanced cancer cells to doxorubicin-, etopside-, or paclitaxel-induced cell death.
Table S1. The combination effect of rsCD40L with cisplatin in SKOV3 cells was quantitatively evaluated using combination index (CI) analysis.
|CAS_2122_sm_fS1.tif||2410K||Supporting info item|
|CAS_2122_sm_tS1.doc||29K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.